The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 136, No 1, 67-70.
© 2005 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EICHMILLER, F. C.
Right arrow Articles by CAREY, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by EICHMILLER, F. C.
Right arrow Articles by CAREY, C. M.
Related Collections
Right arrow Periodontics

CLINICAL PRACTICE

CASE REPORT

JADA Continuing Education

Controlling the fluoride dosage in a patient with compromised salivary function



FREDERICK C. EICHMILLER, D.D.S., NAOMI EIDELMAN, Ph.D. and CLIFTON M. CAREY, Ph.D.

Background. High-concentration topical fluorides are used commonly to prevent caries in patients with compromised salivary function due to irradiation and chemotherapy.

Case Description. The authors describe a 50-year-old man with previously treated cancer who was using tray-applied topical fluoride gel. He complained of gastric symptoms, difficulty in swallowing, leg muscle soreness and knee joint soreness. A computed tomographic scan revealed thickening of the esophageal walls. An upper endoscopy revealed abnormal motility. The motility test indicated high-amplitude peristalsis and hypertensive lower esophageal sphincter, and urine testing indicated high levels of systemic fluoride. The patient’s fluoride regimen was altered, and within a short period his urinary fluoride levels returned to normal and his symptoms resolved.

Clinical Implications. Clinicians prescribing home-applied high-concentration fluorides need to be cognizant of the symptoms of fluoride toxicity, carefully monitor the patient’s compliance with the treatment regimen, and adjust the dosage or mode of application to control the total ingested dose of fluoride.

Key Words: Fluoride; fluoride gel; toxicity; urinary fluoride







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2005 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.